Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for

Jason E Ekert1, Kjell Johnson2, Brandy Strake1

  • 1Biologics Research, Biotechnology Center of Excellence, Janssen R&D, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania, United States of America.

Plos One
|March 19, 2014
PubMed
Summary

Three-dimensional (3D) spheroid cultures, unlike 2D monolayers, alter lung tumor cell responses to growth factors and targeted therapies, offering a more physiologically relevant model for cancer research.